A distinctive pharmaceutical company

Our adventure began in Barcelona in 2003, when three friends in their twenties decided to start up in the pharmaceutical sector. At a time when the dotcoms were proliferating, Galenicum broke into a fairly traditional space.

Even though in the beginning, the business of Galenicum was limited to trading of active pharmaceutical ingredients (APIs) for generics’ companies in Spain, the activity very quickly expanded to encompass the full value chain, including: research and development, regulatory affairs, manufacturing and supply of a broad range of medicines in any part of the world.

Our positioning as ‘specialty pharma’ sums up our ambition in research and development, as well as in operations to fulfil our purpose: to keep improving the quality and affordability of medicines worldwide.

An entrepreneurial free-spirit along with a close, reliable and flexible service to clients, have driven our conscious growth since day one. Today, Galenicum is an ecosystem of several businesses with commercial presence in over 50 countries, covering the full pharmaceutical value chain.

Value Chain

  • icon-0101-challenge-20210421155847.svg

    Trading of Active Pharmaceutical Ingredients (APIs)

  • icon-0101-challenge-20210421155847.svg

    Intellectual Property and Patents

  • icon-0101-challenge-20210421155847.svg

    Research and Development of Finished Dosage Forms (FDFs)

  • icon-0101-challenge-20210421155847.svg

    Regulatory Affairs

  • icon-0101-challenge-20210421155847.svg

    Manufacturing

  • icon-0101-challenge-20210421155847.svg

    Supply and Commercialisation

The Grand Journey

‘The Grand Journey’ is the first episode of a trilogy of short films around the renovation of an old industrial warehouse, which has become the new Galenicum headquarters and R&D Center in 2022.


Our History

2003
  • 2003

    GALENICUM FOUNDED IN BARCELONA

  • 2007

    First authorisation of generic products in Spain

  • 2009

    Awarding of the first patent for Galenicum

  • 2010

    Incorporation of the GSI branch of food ingredients

  • 2012

    Opening of offices in Chile, Peru and Brazil

  • 2013

    Acquisition of a manufacturing plant in Madrid - SAG. Launch of our own B2C brand Galenicum 'Vitae'

  • 2014

    Recognition as 'Business of the Year' in the European Business Awards

  • 2015

    Incorporation of the dermatogical business branch

  • 2016

    Launch of the food supplement line

  • 2018

    First product developed by Galenicum approved by the US FDA. Opening of the office in Colombia.

  • 2019

    Creation of the 'Galenicum Ecosystem' to reorganise and boost the business and operations

  • 2020

    Management of the Covid-19 crisis, recognized as one of the top suppliers.

  • 2021

    New site openings. India, Ecuador and Mexico. Best year in business numbers in the history of the company

  • 2022

    Facing new challenges.

2022

Thanks for your interest in Galenicum. We will get back to you if your profile is a match.